Astria Therapeutics, Inc. Expected to Post Q1 2024 Earnings of ($0.36) Per Share (NASDAQ:ATXS)

Astria Therapeutics, Inc. (NASDAQ:ATXS – Free Report) – Wedbush upped their Q1 2024 earnings per share (EPS) estimates for shares of Astria Therapeutics in a research report issued on Monday, March 4th. Wedbush analyst L. Chico now anticipates that the biotechnology company will post earnings per share of ($0.36) for the quarter, up from their […]

Leave a Reply

Your email address will not be published.

Previous post Alphatec Holdings, Inc. Expected to Earn Q1 2024 Earnings of ($0.23) Per Share (NASDAQ:ATEC)
Next post Vincerx Pharma, Inc. (NASDAQ:VINC) Forecasted to Earn FY2024 Earnings of ($1.04) Per Share